SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BOCHNOWSKI JAMES J

(Last)

(First)

(Middle)

3000 SAND HILL ROAD,

1-135

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/13/2015

3. Issuer Name and Ticker or Trading Symbol
Jaguar Animal Health, Inc. [ JAGX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	98,888	I	By Bochnowski Family Trust⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Preferred Stock	⁽²⁾	⁽²⁾	Common Stock	148,332	⁽²⁾	I	By Bochnowski Family Trust⁽¹⁾
Warrant (right to buy)	02/05/2014	02/05/2019	Common Stock	98,888	$2.5281	I	By Bochnowski Family Trust⁽¹⁾
Warrant (right to buy)	12/23/2014	12/31/2017	Common Stock	22,321	$5.6	I	By Bochnowski Family Trust⁽¹⁾
Stock Option (right to buy)⁽³⁾	⁽⁴⁾	06/02/2024	Common Stock	39,410	$4.83	D
Convertible Promissory Note	⁽⁵⁾	⁽⁵⁾	Common Stock	35,714	$5.6	I	By Bochnowski Family Trust⁽¹⁾
Convertible Promissory Note	⁽⁶⁾	⁽⁶⁾	Common Stock	44,642	$5.6	I	By Bochnowski Family Trust⁽¹⁾

Explanation of Responses:

1. The Reporting Person is a co-trustee and beneficiary of such trust, and shares voting and investment control over such shares with his spouse.

2. The 222,499 shares of Series A Preferred Stock shall automatically convert into 148,332 shares of common stock immediately prior to the consummation of Issuer's initial public offering (the "IPO") and have no expiration date.

3. Granted pursuant to the Issuer's 2013 Equity Incentive Plan.

4. 25% of the Option vested on 03/02/2015, with the remainder vesting equally over the next 27 months such that the option is vested in full on 06/02/2017. Vesting is subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

5. Convertible Promissory Note in the original principal amount of $200,000. Will convert into shares of common stock upon the closing of the IPO into shares of common stock at a conversion price equal to $5.60 per share.

6. Convertible Promissory Note in the original principal amount of $250,000. Will convert into shares of common stock upon the closing of the IPO into shares of common stock at a conversion price equal to $5.60 per share.

	/s/ John A. Kallassy, Attorney-in-Fact	05/13/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.